Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value

nytimes.com/2025/11/21/health/eli-lilly-one-trillion-value-pharmaceuticals.html

Eli Lilly, based in Indianapolis, has surged in large part because of the company’s success in commanding the GLP-1 weight loss drug market.

This story appeared on nytimes.com, 2025-11-21 21:25:40.
The Entire Business World on a Single Page. Free to Use →